Number of deaths from COVID-19 was 68.9 percent lower than in 2022
THURSDAY, Aug. 8, 2024 (HealthDay News) — In 2023, there was a provisional total of 3,090,582 deaths in the United States, according to research published in the Aug. 8 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Farid B. Ahmad, M.P.H., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues examined mortality in the United States using provisional data, based on preliminary death certificate data, for 2023.
The researchers found a provisional total of 3,090,582 deaths in the United States in 2023. The age-adjusted death rate was 884.2 and 632.8 per 100,000 population among males and females, respectively. The overall rate was 6.1 percent lower than in 2022 (750.4 versus 798.8). All age groups had a decrease in the overall rate. In 2023, the overall age-adjusted deaths rates were lowest and highest for non-Hispanic multiracial and non-Hispanic Black or African American persons, respectively (352.1 and 924.3, respectively). Heart disease, cancer, and unintentional injury were the leading causes of death. The number of deaths from COVID-19 was 68.9 percent lower than in 2022 (76,446 versus 245,614).
“Provisional death estimates can give researchers and policymakers an early signal about shifts in mortality trends and provide actionable information sooner than do the final mortality data,” the authors write. “These data can guide public health policies and interventions that are intended to reduce mortality.”
Active Smoking Linked to Progression of Sickle Cell Retinopathy
Low Levels of Placental Growth Factor in Pregnancy Linked to Subsequent ADHD in Offspring
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate
Implant, Patient Survival Do Not Differ for Robotic and Conventional Total Joint Replacement
Physical Therapist-Supervised Exercise Improves Outcomes After ACL Reconstruction
Early Complications Common in Older Kidney Transplant Recipients
PET/MRI Offers Diagnostic, Prognostic Value in Pediatric Epilepsy
Less Intraoperative Crystalloid Fluid Not Tied to Worse Surgical Outcomes